HK Stock MarketDetailed Quotes

DONGFANG ELEC (01072)

Watchlist
  • 39.080
  • -0.740-1.86%
Market Closed Apr 30 16:05 CST
135.15BMarket Cap27.99P/E (TTM)

DONGFANG ELEC (01072) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
5.68%17.22B
13.11%77.58B
16.41%54.74B
14.26%37.62B
10.06%16.29B
15.15%68.59B
7.07%47.03B
12.21%32.93B
2.55%14.8B
9.92%59.57B
Special items of operating revenue
-1.38%253.58M
-6.33%1.03B
-5.60%777.63M
-0.23%527.32M
2.23%257.13M
-0.69%1.1B
-2.59%823.76M
-7.16%528.54M
-11.53%251.52M
-5.45%1.11B
Operating income
5.57%17.47B
12.80%78.62B
16.03%55.52B
14.03%38.15B
9.93%16.55B
14.86%69.7B
6.89%47.85B
11.84%33.46B
2.28%15.05B
9.60%60.68B
Operating expenses
-4.97%-14.26B
-10.77%-65.22B
-15.19%-46.32B
-12.45%-31.81B
-11.02%-13.58B
-17.58%-58.88B
-10.85%-40.21B
-16.73%-28.29B
-3.15%-12.23B
-10.65%-50.07B
Special  items of gross profit
1.38%-253.58M
6.33%-1.03B
5.60%-777.63M
0.23%-527.32M
-2.23%-257.13M
0.69%-1.1B
2.59%-823.76M
7.16%-528.54M
11.53%-251.52M
5.45%-1.11B
Gross profit
9.23%2.96B
27.28%12.37B
23.65%8.42B
25.31%5.82B
5.50%2.71B
2.36%9.72B
-10.89%6.81B
-9.23%4.64B
-0.22%2.57B
6.22%9.49B
Selling expenses
-5.08%-162.61M
-3.08%-847.67M
-10.21%-499.51M
-9.87%-317.89M
-10.60%-154.75M
-7.22%-822.36M
57.27%-453.22M
57.96%-289.34M
51.77%-139.92M
48.30%-766.95M
Administrative expenses
-1.56%-680.31M
-7.34%-3.78B
-1.50%-2.05B
-2.48%-1.37B
5.30%-669.87M
-3.50%-3.52B
5.76%-2.02B
0.17%-1.34B
-6.76%-707.36M
-9.20%-3.4B
Research and development expenses
7.55%-652.66M
-8.38%-3.26B
-11.62%-2.23B
-16.45%-1.57B
-15.24%-705.99M
-9.44%-3.01B
-17.04%-2B
-25.88%-1.35B
-18.05%-612.62M
-20.85%-2.75B
Profit from asset sales
154.38%3.25M
-63.87%5.95M
-62.53%5.33M
2,907.99%3.5M
291.45%1.28M
68.44%16.45M
131.76%14.22M
-97.61%116.26K
1,016.77%326.28K
-80.54%9.77M
Revaluation surplus
728.28%370.19M
141.40%84.52M
-177.77%-19.55M
-365.54%-75.26M
119.98%44.69M
-340.01%-204.16M
-57.73%25.14M
-41.73%28.34M
-774.56%-223.64M
238.22%85.06M
-Changes in the fair value of other assets
728.28%370.19M
141.40%84.52M
-177.77%-19.55M
-365.54%-75.26M
119.98%44.69M
-340.01%-204.16M
-57.73%25.14M
-41.73%28.34M
-774.56%-223.64M
238.22%85.06M
Impairment and provision
-76.39%-253.25M
-46.58%-1.9B
-234.52%-901.81M
-172.39%-666.5M
-16.82%-143.58M
-92.68%-1.29B
50.94%-269.58M
47.69%-244.69M
52.30%-122.91M
-230.38%-671.59M
-Other impairment is provision
-76.39%-253.25M
-46.58%-1.9B
-234.52%-901.81M
-172.39%-666.5M
-16.82%-143.58M
-92.68%-1.29B
50.94%-269.58M
47.69%-244.69M
52.30%-122.91M
-230.38%-671.59M
Operating interest expense
-56.18%-8.42M
3.78%-23.76M
-1.99%-19.22M
-15.81%-13.61M
-54.93%-5.39M
22.73%-24.7M
23.19%-18.85M
40.72%-11.75M
72.50%-3.48M
68.92%-31.96M
Special items of operating profit
-6.47%428.48M
-21.49%2.71B
2.61%1.37B
2.69%917.99M
-1.18%458.14M
48.66%3.45B
10.86%1.34B
7.05%893.95M
4.50%463.61M
28.55%2.32B
Adjustment items of operating profit
---0.01
----
----
----
----
----
----
----
----
----
Operating profit
31.54%1.91B
24.52%4.9B
18.54%3.78B
16.26%2.51B
24.89%1.45B
-1.31%3.93B
-0.77%3.19B
-4.26%2.16B
-4.93%1.16B
23.52%3.98B
Financing income
-64.30%4.96M
-18.46%108.21M
-35.31%62.16M
16.86%49.96M
-41.33%13.89M
9.90%132.71M
70.94%96.09M
78.00%42.75M
120.77%23.68M
184.39%120.75M
Financing cost
30.08%-11.78M
25.78%-61.58M
-26.69%-54.98M
-22.04%-35.32M
-13.98%-16.85M
-28.76%-82.97M
8.45%-43.4M
-8.35%-28.94M
-1.54%-14.79M
18.86%-64.44M
Special items of earning before tax
-179.95%-13.7M
313.97%6.87M
-188.30%-7.4M
-240.47%-12.42M
-166.10%-4.89M
-110.89%-3.21M
-20.17%8.38M
-21.50%-3.65M
5,148.23%7.4M
618.70%29.48M
Earning before tax
27.96%1.8B
23.19%4.79B
18.63%3.73B
18.38%2.49B
23.64%1.41B
-3.04%3.88B
-3.86%3.14B
-9.45%2.11B
-5.48%1.14B
20.40%4.01B
After-tax profit from continuing operations
27.48%1.57B
20.64%3.97B
12.12%3.1B
13.95%2.06B
24.62%1.23B
-9.78%3.29B
-9.04%2.77B
-13.72%1.81B
-8.88%985.39M
20.90%3.64B
Earning after tax
27.48%1.57B
20.64%3.97B
12.12%3.1B
13.95%2.06B
24.62%1.23B
-9.78%3.29B
-9.04%2.77B
-13.72%1.81B
-8.88%985.39M
20.90%3.64B
Minority profit
-126.91%-19.97M
-63.15%134.68M
-4.50%135.33M
29.01%151.05M
-6.82%74.21M
291.60%365.42M
9.31%141.71M
24.48%117.08M
27.57%79.64M
-40.12%93.32M
Profit attributable to shareholders
37.41%1.59B
31.11%3.83B
13.02%2.97B
12.91%1.91B
27.39%1.15B
-17.70%2.92B
-9.86%2.62B
-15.52%1.69B
-11.12%905.75M
24.23%3.55B
Basic earnings per share
24.32%0.46
22.34%1.15
7.14%0.9
11.11%0.6
27.59%0.37
-17.54%0.94
-9.68%0.84
-15.63%0.54
-11.31%0.29
23.91%1.14
Diluted earnings per share
24.32%0.46
22.34%1.15
7.14%0.9
11.11%0.6
27.59%0.37
-17.54%0.94
-9.68%0.84
-15.63%0.54
-11.31%0.29
23.91%1.14
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 5.68%17.22B13.11%77.58B16.41%54.74B14.26%37.62B10.06%16.29B15.15%68.59B7.07%47.03B12.21%32.93B2.55%14.8B9.92%59.57B
Special items of operating revenue -1.38%253.58M-6.33%1.03B-5.60%777.63M-0.23%527.32M2.23%257.13M-0.69%1.1B-2.59%823.76M-7.16%528.54M-11.53%251.52M-5.45%1.11B
Operating income 5.57%17.47B12.80%78.62B16.03%55.52B14.03%38.15B9.93%16.55B14.86%69.7B6.89%47.85B11.84%33.46B2.28%15.05B9.60%60.68B
Operating expenses -4.97%-14.26B-10.77%-65.22B-15.19%-46.32B-12.45%-31.81B-11.02%-13.58B-17.58%-58.88B-10.85%-40.21B-16.73%-28.29B-3.15%-12.23B-10.65%-50.07B
Special  items of gross profit 1.38%-253.58M6.33%-1.03B5.60%-777.63M0.23%-527.32M-2.23%-257.13M0.69%-1.1B2.59%-823.76M7.16%-528.54M11.53%-251.52M5.45%-1.11B
Gross profit 9.23%2.96B27.28%12.37B23.65%8.42B25.31%5.82B5.50%2.71B2.36%9.72B-10.89%6.81B-9.23%4.64B-0.22%2.57B6.22%9.49B
Selling expenses -5.08%-162.61M-3.08%-847.67M-10.21%-499.51M-9.87%-317.89M-10.60%-154.75M-7.22%-822.36M57.27%-453.22M57.96%-289.34M51.77%-139.92M48.30%-766.95M
Administrative expenses -1.56%-680.31M-7.34%-3.78B-1.50%-2.05B-2.48%-1.37B5.30%-669.87M-3.50%-3.52B5.76%-2.02B0.17%-1.34B-6.76%-707.36M-9.20%-3.4B
Research and development expenses 7.55%-652.66M-8.38%-3.26B-11.62%-2.23B-16.45%-1.57B-15.24%-705.99M-9.44%-3.01B-17.04%-2B-25.88%-1.35B-18.05%-612.62M-20.85%-2.75B
Profit from asset sales 154.38%3.25M-63.87%5.95M-62.53%5.33M2,907.99%3.5M291.45%1.28M68.44%16.45M131.76%14.22M-97.61%116.26K1,016.77%326.28K-80.54%9.77M
Revaluation surplus 728.28%370.19M141.40%84.52M-177.77%-19.55M-365.54%-75.26M119.98%44.69M-340.01%-204.16M-57.73%25.14M-41.73%28.34M-774.56%-223.64M238.22%85.06M
-Changes in the fair value of other assets 728.28%370.19M141.40%84.52M-177.77%-19.55M-365.54%-75.26M119.98%44.69M-340.01%-204.16M-57.73%25.14M-41.73%28.34M-774.56%-223.64M238.22%85.06M
Impairment and provision -76.39%-253.25M-46.58%-1.9B-234.52%-901.81M-172.39%-666.5M-16.82%-143.58M-92.68%-1.29B50.94%-269.58M47.69%-244.69M52.30%-122.91M-230.38%-671.59M
-Other impairment is provision -76.39%-253.25M-46.58%-1.9B-234.52%-901.81M-172.39%-666.5M-16.82%-143.58M-92.68%-1.29B50.94%-269.58M47.69%-244.69M52.30%-122.91M-230.38%-671.59M
Operating interest expense -56.18%-8.42M3.78%-23.76M-1.99%-19.22M-15.81%-13.61M-54.93%-5.39M22.73%-24.7M23.19%-18.85M40.72%-11.75M72.50%-3.48M68.92%-31.96M
Special items of operating profit -6.47%428.48M-21.49%2.71B2.61%1.37B2.69%917.99M-1.18%458.14M48.66%3.45B10.86%1.34B7.05%893.95M4.50%463.61M28.55%2.32B
Adjustment items of operating profit ---0.01------------------------------------
Operating profit 31.54%1.91B24.52%4.9B18.54%3.78B16.26%2.51B24.89%1.45B-1.31%3.93B-0.77%3.19B-4.26%2.16B-4.93%1.16B23.52%3.98B
Financing income -64.30%4.96M-18.46%108.21M-35.31%62.16M16.86%49.96M-41.33%13.89M9.90%132.71M70.94%96.09M78.00%42.75M120.77%23.68M184.39%120.75M
Financing cost 30.08%-11.78M25.78%-61.58M-26.69%-54.98M-22.04%-35.32M-13.98%-16.85M-28.76%-82.97M8.45%-43.4M-8.35%-28.94M-1.54%-14.79M18.86%-64.44M
Special items of earning before tax -179.95%-13.7M313.97%6.87M-188.30%-7.4M-240.47%-12.42M-166.10%-4.89M-110.89%-3.21M-20.17%8.38M-21.50%-3.65M5,148.23%7.4M618.70%29.48M
Earning before tax 27.96%1.8B23.19%4.79B18.63%3.73B18.38%2.49B23.64%1.41B-3.04%3.88B-3.86%3.14B-9.45%2.11B-5.48%1.14B20.40%4.01B
After-tax profit from continuing operations 27.48%1.57B20.64%3.97B12.12%3.1B13.95%2.06B24.62%1.23B-9.78%3.29B-9.04%2.77B-13.72%1.81B-8.88%985.39M20.90%3.64B
Earning after tax 27.48%1.57B20.64%3.97B12.12%3.1B13.95%2.06B24.62%1.23B-9.78%3.29B-9.04%2.77B-13.72%1.81B-8.88%985.39M20.90%3.64B
Minority profit -126.91%-19.97M-63.15%134.68M-4.50%135.33M29.01%151.05M-6.82%74.21M291.60%365.42M9.31%141.71M24.48%117.08M27.57%79.64M-40.12%93.32M
Profit attributable to shareholders 37.41%1.59B31.11%3.83B13.02%2.97B12.91%1.91B27.39%1.15B-17.70%2.92B-9.86%2.62B-15.52%1.69B-11.12%905.75M24.23%3.55B
Basic earnings per share 24.32%0.4622.34%1.157.14%0.911.11%0.627.59%0.37-17.54%0.94-9.68%0.84-15.63%0.54-11.31%0.2923.91%1.14
Diluted earnings per share 24.32%0.4622.34%1.157.14%0.911.11%0.627.59%0.37-17.54%0.94-9.68%0.84-15.63%0.54-11.31%0.2923.91%1.14
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More